WBUHS revises entrance exam schedule for Post Doctoral Certificate, Fellowship courses, Applications Open till December 30

West Bengal- West Bengal University of Health Sciences (WBHUHS) has revised the dates of entrance examinations for Post Doctoral Certificate Courses and Post Doctoral Fellowship Courses for the academic year 2024.

As per the revised schedule, candidates willing to take admission to the Post Doctoral Certificate Courses and Post Doctoral Fellowship Courses 2024 can now apply till 30 December 2024. However, all the applications that are submitted for the courses till date will stand valid for processing and the respective candidate need not apply once more. With this, the demand draft of Rs. 10,000/- drawn in favour of “The West Bengal University of Health Sciences”, payable at Kolkata will also have to be purchased on or before 30 December.

Thereafter, the provisional list of candidates eligible for the entrance exam will be published on January 10, 2024, and the final list of candidates eligible for the entrance exam will be published on January 14, 2025.

The entrance exam will be held on January 17, 2024, from 12:00 PM to 1:20 PM. Therefore, candidates who will appear for the said exams can download the admit card on January 15, 2024, from 3:00 PM. The results will be declared on January 24, 2025, on the official website of WBUHS.

REVISED SCHEDULE

S.NO

ACTIVITIES

DATES

1

Last date of Application.

30 December 2024

2

Date of Publication of Provisional list of eligible Candidates for Admission Test.

10 January 2024

3

Dates of Claim and Objections.

13 January 2025

4

Date of publication of Final List of Eligible Candidates for Admission Test.

14 January 2025

5

Admit Card to be downloaded (tentative).

15 January 2024; 3.00 pm

6

Entrance Examination (tentative).

17 January 2025

7

Time of Entrance Examination (tentative).

12:00 noon – 1:20 pm

8

Declaration of Results (tentative).

24 January 2025

However, all other information regarding the courses and the eligibility to appear in the examinations will remain unchanged.

To view the revised schedule, click the link below

https://medicaldialogues.in/pdf_upload/wbhuhs-releases-revised-schedule-for-post-doctoral-entrance-exams-2024-applications-open-until-december-30-265567.pdf

Powered by WPeMatico

Gone on Hold: NMC Keeps 150 MBBS seat limit imposed on Medical Colleges on Abeyance

New Delhi: In a major relief to the medical colleges, the National Medical Commission (NMC) has put the upper limit of 150 seats for the MBBS course on hold. 

Even though the MSR 2023 guidelines had specified that medical colleges seeking an increase in medical seats cannot exceed 150 MBBS seats, the Apex Medical Commission has decided to keep these rules on abeyance for the academic year 2025-2026.

Medical Dialogues had earlier reported that releasing the “Guidelines for Under Graduate Courses under Establishment of New Medical Institutions, Starting of New Medical Courses, Increase of Seats for Existing Courses & Assessment and Rating Regulations, 2023”, which were published in the official Gazette on August 16, 2023, NMC had stated that the intake capacity for the new medical colleges being set up from the academic year 2024-2025 would be restricted to a maximum number of 150 MBBS seats.

While specifying the objectives of the 2023 guidelines, NMC mentioned, “These regulations shall be applicable for Medical Colleges being established from the academic session 2024-25 onwards. Applications for establishing new undergraduate medical education colleges shall be allowed only for 50/100/150 seats.”

Also Read: NMC Rule to Cap MBBS Seats per population on Hold till Academic Year 2024-25: MoS Health informs Parliament

These guidelines also mentioned that after the Academic Year 2023-2024, the Letter of Permission (LoP) for starting new medical colleges would be issued only for an annual intake capacity of 50/100/150 seats, provided that medical college shall follow the ratio of 100 MBBS seats for 10 lakh population in that State/U.T. However, these rules were put on hold for a year after the Health Ministry faced a pushback in this regard from the States.

Recently, issuing a notice on 19.12.2024, the Medical Assessment and Rating Board (MARB) of NMC specified the conditions to apply for the establishment of new medical colleges/institutions intending to offer MBBS courses and increase of MBBS seats in an established medical institute for the Academic Year 2025-2026.

NMC MARB mentioned in the notice that the medical college/institute applying for new medical colleges or increase of MBBS seats would have to strictly comply with the relevant Regulations, MSR Documents, Guidelines, relevant orders, notices and circulars issued by the NMC and other authorities from time to time.

Also Read: What are the conditions to apply for new medical colleges, MBBS seat increase? NMC specifies

The Commission also referred to the MSR rule of specifying an upper limit of 150 MBBS students from the academic year 2024-2025 which states the following:

“(i) College seeking increased number of seats cannot exceed a total of 150 MBBS students from the year 2024-25. Provided that medical college shall follow the ratio of 100 MBBS seats for 10 lakh population in the state/U.T.”

Referring to the MSR rule of specifying an upper limit of 150 MBBS students, NMC mentioned, “The following Objective mentioned under Chapter-I of UG-MSR 2023 notified on 16/08/2023, are kept in abeyance for Academic year (AY:2025-26).”

As per the latest media report by Babushahi.com, MP Sanjeev Arora referred to the NMC decision of putting the 150 MBBS seats on hold, mentioning it to be “…landmark decision enables colleges to apply for additional seats based on their infrastructure.”

He had written letters to both J P Nadda and Mandaviya mentioning that “there is a cap of 150 MBBS seats for all Medical Colleges. This has an ambiguity as Medical Colleges with history cannot be in same league as new hospitals. His suggestion is that older Medical Colleges should be eligible for more MBBS seats as long as they fulfill the criteria of infrastructure.”

Also Read: NMC Guidelines Put 150 MBBS Seats Intake Cap on New Medical Colleges set up from next year

Powered by WPeMatico

No Health Data shared with Insurance, Pharma companies without consent: Shri Prataprao Jadhav

New Delhi: The Minister of State for Health, Prataprao Jadhav informed that the Government of India implemented the Health Data Management Policy (HDM Policy), which came into effect on December 14, 2020. This policy aims to establish minimum standards for privacy, data protection, and the ethical handling of health data within the evolving healthcare ecosystem, particularly under the Ayushman Bharat Digital Mission (ABDM).

The Health Data Management Policy also includes strict regulations on data storage. Health data shared for specific purposes cannot be stored for longer than necessary for those purposes.

Moreover, the principle of data minimization is enshrined in the policy. This principle requires that only the minimum necessary data be shared, ensuring that no excessive or irrelevant health information is disclosed to third parties.

Also Read: No proposal to set up AIIMS in Ballia: MoS Health informs Lok Sabha

The minister was responding to the questions posed by Shri Manoj Kumar Jha about whether patient health data is shared with insurance and/or pharmaceutical companies under the Health Data Management Policy, if so, the extent and nature of such data sharing;

He seeks to know whether the Ministry has established clear limitations on the use of such data by insurance and pharmaceutical companies; and

He also asked about the steps taken by the Ministry to ensure adherence to these limitations by pharmaceutical companies.

Also Read: India has 1.18 crores Hepatitis B cases: MoS Health informs Rajya Sabha

In response to these questions, MoS Health Minister Prataprao Jadhav informed that the Health Data Management Policy (HDM Policy) was released on 14th Dec 2020 by the Ministry of Health and Family Welfare, the government of India. It is a guidance document that sets out the minimum standards for privacy and data protection that should be followed by all the participants/stakeholders of the Ayushman Bharat Digital Mission (ABDM) ecosystem. Health data management policy specifies that no data shall be shared with any other entity including insurance and pharmaceutical companies without the consent of the individual.

A purpose-based limitation on sharing of data has been imposed on health information users (HIUs). Also, the entity to which data is shared (health information user) would not further disclose the data without obtaining the consent of the data principal (the individual). The data shared would also not be stored beyond the period necessary for the purpose specified while obtaining the prior consent of the individual. In addition, the principle of data minimization will also have to be adhered to by the entity which has received the shared data, added the Minister.

Powered by WPeMatico

8th National Siddha Day: Contribution of Siddha in National Ayush Mission Commendable, says AYUSH Secretary

Chennai: Union Minister of State (Independent Charge) for AYUSH and MoS for Health and Family Welfare, Shri Prataprao Jadhav has stated that Tamil Nadu is effectively implementing the National AYUSH Mission. 

The 8th National Siddha Day was celebrated on (19.12.2024). To commemorate this occasion, the Central Council for Research in Siddha, the National Institute of Siddha, and the Directorate of Indian Medicine and Homeopathy of Tamil Nadu jointly organized a function at the Anna Centenary Library Auditorium in Chennai.

Dr Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, graced the occasion as the special guest. Union Minister of State for AYUSH, Shri Prataprao Jadhav, addressed the gathering through a video message.

Speaking on the occasion, the minister mentioned that the Central Government under the leadership of Prime Minister Narendra Modi has created a separate Ministry for Indian systems of medicine. He further stated that the Ministry of AYUSH has been working effectively in the last eight years to promote these systems of medicine. He noted that Siddha systems of medicine have been of great benefit in increasing people’s immunity during the COVID-19 pandemic.

The Union Minister of State, Shri Prataprao Jadhav, also mentioned that the Government of Tamil Nadu is effectively implementing the National AYUSH Mission.

Also Read:AYUSH bringing health and wellness to the world: Minister Sarbananda Sonowal

During the event, Dr. Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, released the third volume (in Tamil) of the Compendium of Siddha Formulary of India and the Soveneir of 8th Siddha Day.

He presented research grants of Rs. 20,000 (for 10 undergraduate students) and Rs. 30,000 (for 5 postgraduate students) respectively to the winners of the Central Government’s Mini Research Project for Siddha Medicine students.

He also presented medals and certificates of appreciation to the university-level toppers. He stated that the Government of Tamil Nadu is a pioneer state in Siddha medicine education and research. He mentioned that there are nearly 900 AYUSH startups operating in the country and that the sector has grown significantly under the leadership of Prime Minister Shri Narendra Modi. He further added that the sector has a bright future.

Shri Vaidya Rajesh Kotecha further mentioned that about 90% of people in rural areas and 95% of people in urban areas are well aware of AYUSH systems of medicine and 50% of them are using AYUSH modalities. He termed this is the golden era of AYUSH.

Shri. Vaidya Rajesh Kotecha also mentioned that 22 apps have been introduced to avail the benefits of AYUSH systems of medicine, Yoga among one of them.

Siddha medicine sessions, herbal exhibitions, etc., were also held on the occasion of the 8th Siddha Day. More than 1600 people including the Director General of the Central Council for Research in Siddha, N.J. Muthukumar, Siddha experts, Siddha professors, Siddha doctors, Siddha researchers, and Siddha students participated in the event.

Also Read:Out of 1000 targeted 750 Ayushman Arogya Mandir achieved NABH AYUSH entry-level certification

Powered by WPeMatico

Indian medical devices sector size expected to grow to USD 30 Billion by 2030: Anupriya Patel

New Delhi: The medical device sector in India is recognized as a sunrise sector because of its immense growth potential driven by the country’s increasing healthcare needs, technological innovations, government support, and emerging market opportunities, said Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel while addressing the plenary session on “Charting India’s MedTech Revolution: MedTech Expansion roadmap to 2047”.

Minister of State (MoS) Patel was speaking at the 21st Health Summit of the Confederation of Indian Industry (CII) here. Union Health Secretary, Smt. Punya Salila Srivastava was also present. The theme of the summit is “Transforming Healthcare for Viksit Bharat 2047”.

She informed that the size of the Indian medical devices sector is estimated to be around $14 billion and it is expected to grow to $30 Billion by 2030. She also highlighted that India is the fourth largest medical devices market in Asia after Japan, China, and South Korea and among the top 20 global medical devices markets in the world.

The Union Minister stated that the MedTech industry is not just a component of healthcare but is the catalyst that links patients, payors, providers, and regulators to create a stronger and more equitable healthcare system. “It is this unique positioning of MedTech that holds the promise of revolutionizing healthcare delivery and outcomes, both in India and globally”, she said.

Highlighting the promise of AI in healthcare, Smt. Patel said, “AI innovation is crucial within healthcare to create new methods for facilitating and tackling healthcare challenges and discovering new opportunities.”

Smt. Patel highlighted the Union Government’s efforts in strengthening the medical device ecosystem, focusing on boosting domestic manufacturing, promoting research, enhancing skill development, and increasing India’s share in the global market.

She stated that “key policy decisions include allowing 100% FDI under the automatic route and the approval of the National Medical Device Policy, 2023, which addresses regulatory streamlining, infrastructure development, R&D, investment attraction, and human resource development. This includes the establishment of Centres of Excellence, courses at NIPERs, and initiatives to strengthen MedTech education.”

The Union Minister noted that the government has taken steps to boost exports and industry collaboration, with the creation of the Export Promotion Council for Medical Devices (EPCMD) and the reconstitution of the National Medical Devices Promotion Council (NMDPC). “These bodies aim to facilitate medical device exports, resolve regulatory challenges, and enhance the Ease of Doing Business, further promoting India’s position in the global medical device market”, she said.

She also informed about the launch of the Scheme for Promotion of Medical Devices Parks with a ₹400 crore outlay, providing ₹100 crore each to Uttar Pradesh, Tamil Nadu, Madhya Pradesh, and Himachal Pradesh for infrastructure development.

“Additionally, the Promotion of Research in Pharma-Medtech Sector (PRIP) and the “Scheme for Strengthening the Medical Device Industry” with ₹500 crore funding aim to foster innovation, enhance manufacturing capabilities, support skill development, and promote industry growth”. These efforts align with the vision of Atmanirbhar Bharat, focusing on self-reliance, innovation, and global competitiveness in the MedTech industry, she said

Underlining that a healthy population fuels productivity, drives economic growth, and ensures social justice, Union Health Secretary, Smt. Punya Salila Srivastava stated that “healthcare is not just a social imperative but an economic necessity.”

She noted that India’s healthcare agenda focuses on making healthcare affordable, accessible, and inclusive for every citizen and stressed that the healthcare sector is a critical component of India’s vision to become a developed country by 2047.

The Union Health Secretary highlighted that investments in robust healthcare and quality education systems are essential for harnessing the nation’s demographic dividend, driving innovation, and ensuring sustainable progress.

She emphasized that India’s healthcare sector has made significant strides with initiatives like PM-JAY, PM-ABHIM, and Ayushman Bharat Digital Mission, expanding access to affordable care. She stated, “The private sector plays a key role in transforming healthcare, particularly in Tier-2 and Tier-3 cities, through value-based care models and technological innovations. Public-private partnerships, preventive healthcare, and a focus on expanding the healthcare workforce will be critical in achieving Universal Health Coverage and positioning India as a global leader”.

Smt. Punya Srivastava also informed the dignitaries about the 100 Days Intensified TB Campaign, launched by the Union Health Minister, Shri JP Nadda in Panchkula on December 7, 2024. She emphasized the importance of supporting the campaign to achieve the goal of eliminating TB by 2025 and encouraged the organizers to hold a brief session on TB in the next two days to further boost the initiative.

She concluded her speech by assuring the government’s commitment to strengthening India’s healthcare ecosystem, with the support of the private sector, healthcare leaders, and civil society. “The goal is to transform India into a global leader in healthcare delivery by 2047, aiming for a healthier, stronger, and prosperous India. The private sector’s role in shaping India’s healthcare future is both a responsibility and an opportunity. By embracing this vision, quality healthcare will be provided to every Indian, driving economic growth and job creation”, she stated.

Dr Naresh Trehan, Chairman, CII National Healthcare Council and Chairman and Managing Director, Medanta – The Medicity; Mr Dilip Jose, Co-Chairman, CII and MD & CEO, Manipal Health Enterprises Pvt. Ltd; Ms. Sunita Reddy, Managing Director, Apollo Hospital Group and Ms. Amita Sarkar, Deputy Director General, CII, were present at the gathering.

Powered by WPeMatico

Strengthening Ayushman Bharat PM-JAY in Response to CAG Audit Findings: MoS Health

New Delhi: The Minister of State for Health, Shri Prataprao Jadhav, shared detailed insights into the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and its operational framework. Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is a flagship healthcare scheme launched by the Government of India to provide health coverage to economically vulnerable families.

The scheme offers free secondary and tertiary hospitalization services, up to Rs. 5 lakh per family per year, and is one of the largest health insurance programs globally.

Under AB-PMJAY, healthcare providers, both public and private, submit pre-authorization requests and claims for treatments provided to beneficiaries. These claims are processed by the respective State Health Agencies (SHAs) or insurance companies contracted by the SHAs. The government is currently conducting audits and studies to assess the performance of AB-PMJAY and is committed to making improvements to the scheme based on the findings of these reviews.

Also Read: Boosting Healthcare by Supporting HealthTech Startups, says MoS Health

The minister was responding to the question raised by Shri Vivek K Tankha about whether, in light of the Comptroller and Auditor General of India (CAG)’s report on Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), Government is considering to adopt NHS-style monitoring practices, such as requiring a General Practitioner (GP) recommendation before beneficiaries access hospital services, to enhance accountability;

He seeks to know whether AB-PMJAY could adopt a system where the government directly pays healthcare providers, inspired by the NHS model, thereby eliminating financial interactions for beneficiaries and simplifying access to services; and

Furthermore, he inquired, whether the Government will implement regular independent audits and performance reviews, incorporating best practices from the NHS, to improve transparency, resource utilization, and service delivery within the AB-PMJAY.

Also Read: No proposal to set up AIIMS in Ballia: MoS Health informs Lok Sabha

In response to these questions, MoS Health Prataprao Jadhav informed that Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is a flagship scheme of the Government which provides health cover of Rs. 5 lacks per family per year for secondary and tertiary care hospitalization to approximately 55 crore beneficiaries corresponding to 12.37 crore families constituting economically vulnerable bottom 40% of India’s population.

Under AB-PMJAY, a network of over 29,929 hospitals has been empaneled to provide healthcare services to the scheme beneficiaries. This includes 13,222 private hospitals.

All eligible beneficiaries are entitled to free healthcare services where they can visit any impaneled hospital to avail of healthcare services across the country.

The Minister further informed that under AB-PMJAY, the empaneled hospitals raise pre-authorization and claim requests to their respective State Health Agencies regarding the treatment given to the scheme beneficiaries. Further, depending on the mode of implementation adopted by the State/UT, the State Health Agencies (SHAs) and/or insurance companies (engaged by respective SHAs) subsequently settle the claims raised by the empaneled hospitals for the treatments availed by the scheme beneficiaries.

The performance audit regarding the implementation of AB PM-JAY for the period September 2018 to March 2021 was conducted by CAG at the request of the National Health Authority (NHA).

A baseline study was commissioned by the Government of India in 2019-2020 to understand the impact of AB-PMJAY across the States of Bihar, Chhattisgarh, Gujarat, Kerala, Meghalaya, Tamil Nadu and Uttar Pradesh covering a sample of 72,636 individuals, added the Minister.

Powered by WPeMatico

NMC extends deadline for medical college faculties to submit assessor willingness forms

The National Medical Commission (NMC) has extended the deadline for the medical college faculties to submit their willingness to become an assessor of the Apex Medical Commission by 15 more days.

While earlier the Medical Assessment and Rating Board (MARB) of the Commission had set the deadline till 18.12.2024, now issuing a new notification on 19.12.2024, NMC has extended the deadline by 15 more days (from 19.12.2024).

For more information, click on the link below:

Powered by WPeMatico

Calcutta HC grants conditional nod for doctors’ protest in RG Kar rape-murder case

The Calcutta High Court on Thursday granted conditional permission to the West Bengal Joint Platform of Doctors, an umbrella group of senior medical professionals, to hold a sit-in demonstration in central Kolkata.

The protest is organized in response to the bail granted to two individuals accused of tampering with evidence in the brutal rape and murder case of a woman postgraduate doctor at RG Kar Medical College & Hospital in August.

For more information, click on the link below:

Powered by WPeMatico

NEET 2024 admissions deadline extended till December 30 by Supreme court

Observing that precious medical seats should not be wasted, the Supreme Court has extended the deadline for National Eligibility-Entrance Test Undergraduate (NEET-UG) admissions till December 30 as a “last chance”.

The Apex Court bench comprising Justices BR Gavai and KV Viswanathan granted the extension after taking into account the number of medical seats remaining vacant despite 5 rounds of counselling.

For more information, click on the link below:

Powered by WPeMatico

National Institute of Siddha sets Guinness world record with mass varmam therapy session

The National Institute of Siddha (NIS) has set a Guinness World Record for providing Varmam therapy to 567 individuals simultaneously.

The event held at the NIS campus in Tambaram, Chennai, highlights the growing recognition of Siddha medicine and its non-invasive, drug-free therapeutic methods, particularly through the practice of Varmam therapy. The Union State Minister of Ayush (Independent Charge) Shri Prataprao Ganpatrao Jadhav appreciated the efforts of NIS in a written message.

For more information, click on the link below:

Powered by WPeMatico